Hequn Yin
Chief Tech/Sci/R&D Officer bei SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO., LTD.
Profil
Derzeit bekleidet Hequn Yin die Position des Chief Scientific Officer der Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Herr Yin war zuvor Vice President-Research & Development bei Pfizer Inc. Er erhielt einen Bachelor-Abschluss von der Peking University, einen Master-Abschluss vom Shanghai Institute of Organic Chemistry und einen Doktortitel von der University of Rochester.
Aktive Positionen von Hequn Yin
Unternehmen | Position | Beginn |
---|---|---|
SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO., LTD. | Chief Tech/Sci/R&D Officer | - |
Ehemalige bekannte Positionen von Hequn Yin
Unternehmen | Position | Ende |
---|---|---|
PFIZER, INC. | Chief Tech/Sci/R&D Officer | 01.02.2019 |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Director/Board Member | 01.11.2017 |
Ausbildung von Hequn Yin
Rochester Christian University | Doctorate Degree |
Peking University | Undergraduate Degree |
Shanghai Institute of Organic Chemistry | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
PFIZER, INC. | Health Technology |
SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO., LTD. | Health Technology |
Private Unternehmen | 1 |
---|---|
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Health Technology |